Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors

Despite the ongoing progress in cancer research, the global cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. Gynecological cancers, such as ovarian, endometrial, and cervical cancers, considerably contribute to global cancer burden, leading to $5,862.6, $2,945.7,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grywalska, Ewelina, Sobstyl, Małgorzata, Putowski, Lechosław, Roliński, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801535/
https://www.ncbi.nlm.nih.gov/pubmed/31547532
http://dx.doi.org/10.3390/ijms20194705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801535/
https://www.ncbi.nlm.nih.gov/pubmed/31547532
http://dx.doi.org/10.3390/ijms20194705

Ejemplares similares